Objective: To test whether or not topically administered recombinant human epidermal growth factor (rhEGF) accelerates the early healing phase of oral soft tissue wounds.
| INTRODUC TI ON
Oral soft tissue repair is characterized by either a primary or a secondary intention healing. Primary intention healing results when the edges of the wound are closely approximated while in secondary intention healing, the wound edges remain distant (Polimeni, Xiropaidis, & Wikesjö, 2006) . Oftentimes, excising diseased gingival tissue, curetting root surfaces, avulsing hopeless teeth or apically positioning the flapped tissues are prevalent clinical scenarios where wound repair exclusively rely upon secondary intention healing (Harrison, 1991) . Open wounds heal de facto with the same basic process of inflammation, proliferation and remodelling as do closed wounds. However, each sequence of the secondary healing wounds takes longer to be completed. A factor of healing delay is the considerable amount of granulation tissue necessary to bridge the distant wound edges in the setting of open injuries (Clark, 1996) .
To accelerate the repair of soft tissue wounds, regenerative medicine approaches have been applied including growth factors used alone or in combination (Kaigler, Cirelli, & Giannobile, 2006) . preclinical and clinical studies resonate that growth factor-driven treatments are helpful boosting the innate healing potential (Schliephake, 2002) . Prominent among these is the strategy whereby epidermal growth factor (EGF) is engaged in productive skin repair (Bodnar, 2013; Brown et al., 1989) . As the first growth factor to be isolated, and one of the first to be synthesized using recombinant DNA technology, EGF has been extensively investigated in dermal wound healing (Brake et al., 1984; Hong, Kim, Jung, & Jung, 2006; Tanaka, Nagate, & Matsuda, 2005) . According to recent systematic reviews, topical interventions using recombinant human EGF (rhEGF) in clinical settings are robust protocols to promote healing of cutaneous aberrations such as diabetic ulcers or burn injuries(Martí-Carvajal, Rojas-Reyes, Reveiz, Rodriguez-Malagon, & Cedeño-Taborda, 2010; Zhang et al.,2016) .
In a similar fashion, this potential of EGF has also captured scientific interest with the endeavour to achieve periodontal regeneration. The available data suggest the promise of EGF purposed at improving oral wound healing. To recapitulate, stimulation of proliferation and migration of oral keratinocytes, stimulation of gingival fibroblasts mitogenesis and increase of collagen synthesis (Kim et al., 2011; Pansani et al., 2017; Ramineni, Fowler, Fisher, Cunningham, & Puleo, 2015) are among the cellular events through which exogenous EGF is harnessed to facilitate the wound repair in vitro.
Nevertheless, whether EGF-based treatment is able to facilitate the repair of acute injuries healing by secondary intention remains unknown. In vivo data are missing in terms of (a) 
| MATERIAL S AND ME THODS

| Animals
Fourteen 1-year-old, 10-kg-weighing beagle dogs were used for the purpose of this experimental study, conducted following approval by the Institutional Animal Care and Use Committee, Cronex, Hwasung, Korea (CRONEX-IACUC 201701001).
All surgical and follow-up interventions were performed under general anaesthesia in an operating room and under sterile conditions. General anaesthesia was induced by the injection of tiletamine/ zolazepam (0.1 mg/kg; Zoletil, France), xylazine(2.3 mg/kg; Rompun, Korea) and atropine sulphate(0.05 mg/kg; Jeil, Korea). Further analgesia was given for 3 days following surgical procedures (Zipan, Korea).
Throughout the experiment period, all animals were housed individually and had ad libitum access to water and laboratory soft dog-food.
| Experimental procedures
| Agents
semisolid preparations were used for the application on the oral mucosa of rhEGF (Daewoong, Korea) adjusted to concentrations of 1, 10 and 50 μg/g. Gelatin, pectin and sodium carboxymethylcellulose plasticized in hydrocarbon gel (Plastibase; Contract Pharmaceuticals, Canada) were used as a carrier of rhEGF.
| Surgical procedures
A total of 84 soft tissue wounds were experimentally created in 14 animals (n = 6/animal; Table S1 ) by adapting a previously reported defect model of the masticatory mucosa of the palate (Thoma, Sancho-Puchades, Ettlin, Hämmerle, & Jung, 2012; Thoma et al., 2016; Ayvazyan et al.,2011; Figure 1a,b) .
10-mm-diameter cylindrical wounds were obtained by harvesting oral soft tissue using a biopsy punch (Acuderm, USA) inserted at a predetermined depth of 3 mm from the surface of the palatal ridges, leaving the periosteum and part of the submucosa exposed. In order to standardize surgical procedures, individual stents with six 10-mm-diameter circular openings served as a guide to symmetrically allocate three equidistant wounds (4 mm) to each hemi-palate ( Figure 1a ).
| Treatment of oral mucosa defects
At day 1 postsurgery, the following treatment modalities were randomly applied to the dogs following an incomplete block design, where animals were considered as experimental units and defects (six per dog) as subunits (Table S1 ):
Clinical Relevance
Scientific rationale for the study: Epidermal growth factor demonstrated to facilitate primary and secondary wound healing of the skin. This study aimed to clinically and histologically verify the effect of topical administration of recombinant human epidermal growth factor (rhEGF) on the early healing of open oral soft tissue wounds.
Principal findings:
In comparison with spontaneously healing wounds, rhEGF not only increased the wound closure rate during the first week, but also significantly improved the quality of the wound healing at 16 days.
Practical implications: RhEGF accelerated the healing of oral soft tissue wounds.
• Spontaneous healing: No ointment administered (negative control group; SH; N = 3 dogs, n = 18 defects).
• Topical application of vehicle (control group control group; V; N = 2 dogs, n = 12 defects).
• Topical application of rhEGF: Three concentrations were tested (1 μg/g (EGF1), 10 μg/g (EGF10), 50 μg/g (EGF50); N = 3 dogs, n = 18 defects for each concentration)
In order to facilitate topical interventions, additional individual stents were prepared with moulding sheets (Durasoft, Germany) F I G U R E 1 (a-d) Surgical procedure, rhEGF administration and follow-up. Using a prefabricated stent (a), punch biopsies were harvested creating six defects on the hard palate mucosa of each dog (b). An equivalent volume (≈240 mm 3 ) of ointment (vehicle, 1, 10 and 50 μg/g) was transferred to the stent using a spatula on the location of each defect. The stent was then applied on the upper jaw, and an intimate contact of both jaws was maintained to immobilize the stents for 10 minutes. In the Spontaneous Healing group, the same procedure was performed, while no ointment was applied on the stent (c). Healing was monitored using clinical photographs and impressions (d) (Bar = 5 mm). e-g: Clinical, three-dimensional and histological analyses. On photographical recordings of the wounds before, immediately after surgery, 4, 8, 12 and 16 days following surgery, the wound area (mm 2 ) was calculated as the surface area covered by unkeratinized tissue (dashed area) (a).
Tissue volume variations were evaluated in regions of interest (ROI V ) on superimposed scans of digitized casts at the different time points (blue: immediately after surgery, grey: at post-surgery day-4) (b). Histological analysis was performed using ROI 1 positioned at the centre of the biopsy along its surface, a rectangular-shaped ROI 2 (8 mm/1.5 mm) and ROI 3 encompassing the epithelium layer (12-mm length segment divided in five equivalent fields of ×200 magnification)
deprived from any medicinal properties ( Figure 1c ). For each defect, 240 mm 3 of the ointment was transferred to the stent, which was then applied on the upper jaw. After 10 minutes, the stent was removed, and the ointment was wiped off from the palatal mucosa.
Administration was repeated twice per day with a 9-hr interval (9 a.m., 6 p.m.) in each dog by laboratory workers blinded to the treatment agents from day 1 post-surgery until animals were euthanized. In the group SH, the same procedure was performed while no ointment was applied on the stent.
| Follow-up
Before surgery, immediately after surgery and at post-surgery days (PSD) 4, 8, 12 and 16, impressions and clinical photographs were taken. Polyether impressions (Impregum F, Germany) of the upper jaws were taken using prefabricated individualized trays (Schmitt et al., 2016) .
Standardized clinical photographs were taken at an angle of 90°
to the upper jaw and a distance of 80 cm using identical resolution, exposure and enlargement (Rennert, Golinko, Kaplan, Flattau, & Brem, 2009 ).
| Biopsies and histological processing
At PSD8 and 16, animals were sacrificed by an intravenous injection of potassium chloride (Jeil, Korea) under general anaesthesia.
Full-thickness mucosa was gently separated from the palatal bone using a periosteal elevator and tissue specimens were separated.
Each biopsy was fixed in 10% neutral-buffered formalin solution and embedded in paraffin. The tissue blocks were sectioned in a frontal plane at the most central aspect of the wounds, and 5-μm-thickness serial slices were cut using a microtome. Three consecutive slides from the centre of the wounds were selected and prepared for staining (Ayvazyan et al., 2011) . The slides were scanned on a highthroughput Panoramic Scan (3DHistech, Hungary), and each section image was visualized using Case viewer (3DHistech). (Rennert et al., 2009 ; Figure 1e ).
| Analyses
| Clinical photograph analysis
| Three-dimensional analysis of the wounds
For volumetric evaluation of tissue repair, impressions obtained before surgery, directly after surgery, and at PSD4, 8, 12 and 16 were poured out (Dentona, Germany). Retrieved casts were optically scanned using an industrial scanner (ATOS II SO4, Germany) and a software (ATOS, Germany) that allowed superimposing the threedimensional data of the virtual dental models (Schmitt et al., 2016 ; Figure 1f ). 
Regions of interest (ROI
| Histological analyses
Following staining with H&E and Masson's trichrome, wound remodelling, inflammation and angiogenesis were histologically assessed by quantitative image analysis of the following parameters ( Figure 1g ):
New epithelium and wound gap
The length of the epithelium covering the wound's connective tissue (New epithelium; μm) and the length of line segment between defect's margins (Wound gap; μm) were calculated (Lemo et al., 2010) .
Granulation tissue and collagen areas
A rectangular region of interest ROI 2 encompassing the central superficial area of the wound was defined to semi-automatically quantify granulation tissue and collagen formation using a digital image software program (Photoshop, Adobe, USA). Masson's trichromestained sections, magnified at 30×, were used to easily distinguish the histological structures through their typical colours such as collagen fibres stained in dark and light blue (Miot & Brianezi, 2010) .
First, in each image, the epithelium and the fibrin clot were manually selected and excluded. The remaining pixels in the ROI 2 indicating the area of the granulation tissue were measured and expressed as a percentage of the total pixels of the ROI 2 . In order to quantify the collagen of the granulation tissue area, collagen pixel red green blue (RGB) values were recorded at five randomly selected points to obtain an average pixel RGB value representative of the collagen content. This RGB value was set as a threshold to select all the blue pixels per image using the Select > Color Range function with a "fuzziness" value of 70 (Grasman, Do, Page, & Pins, 2015) . The thresholded pixels were expressed as a percentage of the granulation tissue area. 
| Immunohistochemical analysis
In order to detect the proliferative pattern of oral keratinocytes in the epithelial compartment, antibody against rabbit anti-Ki-67(ab15580;
Abcam, USA) was used for heat-induced antigen retrieval with a developing at 4°C overnight with secondary antibody kits and DAB as the chromogen according to the respective protocol. The negative control was achieved staining the slide without treatment of the primary antibody to evaluate false positive staining.
The number of positive keratinocytes was calculated using a region of interest (ROI 3 ; Safferling et al., 2013 ; Figure 1 ). 
| Statistical analysis
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| Volumetric assessment of wound repair
The results of the volumetric measurements, summarized in 
PSD16). Statistical significance was observed at PSD8 (i1-i3) between
EGF10 and all groups (p < 0.05) except EGF1; and at PSD12 (i1-i4) and PSD16 (i1-i5) for EGF50 as compared to EGF1 and EGF10 (p < 0.05).
| Histological analysis of healing kinetic
| Epithelium layer
Day 8 post-surgery
Compared with SH, V and EGF50 where sparse and bare epithelial layers were formed at the wound site, epithelial cells showed a clear tendency to migrate from the edges of normal mucosa towards the centre of the wounds in groups EGF1 and EGF10 ( Figure S1 ). As illustrated in Figure 2c , the histomorphometrical measurements showed that the wound gap was the smallest in groups EGF1 and EGF10.
Mean values were 6.37 ± 1.38, 4.75 ± 0.76, 4.22 ± 1.57, 4.67 ± 1.35
and 6.9 ± 0.81 mm in, respectively, groups SH, V, EGF1, EFG10 and EGF50. In addition, EGF1 displayed the longest mean length of new epithelium. The measurements provided mean values of 3.08 ± 1.2, 3.85 ± 1.25, 5.53 ± 1.3, 4.82 ± 0.19 and 3.1 ± 1.31 mm in, respectively,
SH, V, EGF1, EFG10 and EGF50. Statistical difference was observed for the mean wound gap in V, EGF1 and EGF10, in comparison with EGF50
(p < 0.05). Similarly, the difference between epithelium length in EGF1
and EGF10 compared to the other groups was significant (p < 0.05).
Day 16 post-surgery
Wounds were observed to reach full closure by re-epithelialization in the majority of the samples in EGF1 and EGF10 (5/6 and 10/12, respectively), while the epithelium was still not completely formed at the centre of the wounds in SH, V and EGF50 (Figure 4a ). This was verified by the wound gap measurement in groups EGF1 and EGF10
showing the fastest decrease upon PSD16 (6.5-and 5.3-fold, respectively). The mean values of new epithelium length were 7.21 ± 1.63, 7.14 ± 1.43, 12.94 ± 1.44, 11.48 ± 2.49 and 6.58 ± 2.39 mm in SH, V, EGF1, EGF10 and EGF50, respectively. For both histomorphometrical parameters, EGF1 and EGF10 displayed significant differences when compared to group SH and EGF50 (p < 0.05).
| Sub-epithelial layer
Day 8 post-surgery
In all groups, the sub-epithelial region showed fibroblasts migrating from the wound bed and granulation initiating, as the defect site was replaced with regenerating tissue. In the magnified images of the middle region, connective tissue appeared heavily infiltrated with inflammatory cells between which small vessels could be detected with a sporadic distribution of few fibroblasts (Figure 4a , Figure S2 ).
The histomorphometrical analysis showed no differences in vessels proportion between groups. By contrast, EGF10 group harboured the smallest inflammatory infiltrate among all groups (38.9 ± 11%)
as well as the highest proportion of fibroblasts (45.8±26% p < 0.05; 
Day 16 post-surgery
Examining the central subepithelial region of wounds belonging to EGF1 and EGF10, collagen fibres appeared thicker with a corrugated structure, whereas highly disordered in SH, V and EGF50, as evidenced with the H&E staining (Figure 4a ). The histomorphometry showed a significantly higher deposition of F I G U R E 4 (a) Representative H&E staining of the palatal mucosa unwounded or 8 and 16 days following surgery, illustrating the healing process at the centre of the defects (see Figure S2 ). 21.3 ± 5.2%, 24.9 ± 14.5% and 27.9 ± 11.5% in, respectively, SH, V, EGF1, EGF10 and EGF50. The inflammatory infiltrate proportion reached 70.6 ± 11.8%, 42 ± 25.4%, 26.5 ± 23.7%, 13.6 ± 14.6% and 47 ± 31.2% in, respectively, SH, V, EGF1, EGF10 and EGF50. In addition, fibroblasts and vessels proportions remained the highest in EGF10 group with statistical difference as compared to the other groups (p < 0.05).
| Keratinocytes proliferative activity
As shown in Figure 6a , few positive nuclei along the basal cell layer could be observed in the edges of the wounds from SH, V or EGF50 at PSD8 and PSD16. However, a clear increased expression of Ki67 within basal and immediate suprabasal cells was seen from PSD8 to PSD16 in EGF1 and EGF10. This was confirmed by the histomorphometrical analysis demonstrating a significantly higher keratinocytes proliferation in these groups at PSD16 (p < 0.05). The immunoreactivity for Ki67 was 399.2 ± 165.1, 579.4 ± 180.9, 921.9 ± 202.3, 1362.9 ± 564.9 and 340.1 ± 315.51 cells/field in SH, V, EGF1, EGF10
and EGF50, respectively.
| D ISCUSS I ON
There have been through and accelerated efforts to improve oral wound healing. These endeavours have been motivated by the need for a hastened soft tissue healing following periodontal and peri-implant surgery. Although the oral mucosa is endowed with the capacity to repair itself, closure is anticipated to be significantly delayed when surgical wounds are readily exposed to oral bacteria and left to heal by secondary intention. Because complications of open wounds may hamper the treatment outcomes, it is believed that surgical wound healing by secondary intention requires local care (Greenstein et al., 2008) . This study provides a hitherto novel approach for boosting the innate healing potential by which rhEGF is engaged in a productive repair of oral mucosa wounds.
The hypothesis of the present study encompasses not only the study of the rhEGF biological potential, but also the screening of the clinically relevant doses. A total of fourteen dogs were employed to discriminate the dose-dependent effect of rhEGF on oral wound repair. Considering the paucity of the data for the oral mucosa (Kim et al., 2017) , three concentrations were selected in accordance with the literature addressing the treatment of skin wounds in humans (Brown et al., 1989; Fernández-Montequín et al., 2009; Martí-Carvajal et al., 2010; Wang, Ma, & Chai, 2002) or animals (Gainza et al., 2015; Hong et al., 2006) with rhEGF.
Then, rhEGF incorporated in an ointment vehicle was tested in a discriminating pre-clinical model. The experimental standardized wound size, fixed wounding protocol and the use of canine palatal mucosa as a wounding substrate allowed to overcome some of the challenges associated with in vivo wound healing studies, that is, the lack of apposite murine wound healing model for oral soft tissues. The morphological features of oral epithelium and molecular patterns in connective tissue of the healing oral palate from dog are the most similar to humans as compared to other species including rodents and pigs (Sa, Xiong, Ren, Zhao, & He, 2017; Sa et al., 2016) . Here, the harvested tissues with a mean thickness varying between 1.32 and 1.49 mm resulted in defects that included epithelium, lamina propria and submucosa. Sampling was performed at one and two weeks after excisional wounding, time points at which the healing masticatory mucosa exhibited typical signs of erythema/oedema or wound closure, respectively (Häkkinen, Larjava, & Koivisto, 2012) . Given the excisional nature of the wounds, healing requires the closure of the wound site by formation of new connective tissue and coverage by epithelium, events that might be impaired by direct insults from the oral commensal flora (Nooh & Graves, 2003) . Growth factors, such as EGF, are poised to improve wound repair in the present setting of acute excisional injuries (Davidson, Zoia, & Liu, 1993) .
Consistent with this, assumption was the healing in wounds topically treated with rhEGF 1 and 10 μg/g, that is characteristic of a regenerative response including efficient resolution of inflammation, promotion of an extracellular matrix(ECM)-rich granulation tissue and a superior rate of re-epithelialization (Gurtner, Werner, Barrandon, & Longaker, 2008) . A prime example is the rapid closure of the excisions receiving topical preparations in EGF1 and EGF10 as evidenced clinically (gross wound area) and confirmed histologically (wound gap), and may be attributable to a plethora of biochemical events downstream of the binding of EGF to its transmembranic receptors (D'Alessio, Gerasi, & Blasi, 2008; Hashimoto, 2000; McCawley, O'Brien, & Hudson, 1998; Nickoloff, Mitra, Riser, Dixit, & Varani, 1988) . In the same vein, the analysis of the proliferative activity as reflected by Ki-67, a protein produced in mitosis G1 and S phases, was found to be superior in sites receiving 1 and 10 μg/g of rhEGF as compared to EGF50 and controls at PSD8 and PSD16. In contrast with the impaired wound closure observed in EGF50, the overall quicker reconstruction of the epithelium in EGF1 and EGF10 confirms previous reports using settings of skin wounds in pigs (Hong et al., 2006) or humans (Yang, Geng, Ma, Sun, & Fu, 2016) .
Once the epithelial barrier has been re-established, remodelling of the granulation tissue concomitant with the deposition of cross-linked collagen fibres is key events in the course of oral mucosa healing (Weinreb & Nemcovsky, 2015) . Comparably to previous studies, the significant production of hypercellular granulation tissue (Kondo, Niiyama, Yu, & Kuroyanagi, 2012) at 8 days as well as the substantial deposition of highly organized collagen (Gainza et al., 2015) at 16 days illustrates herein the faster healing in rhEGF-treated sites, particularly with the 1 and 10 μg/g regimen at the opposite of the 50 μg/g concentration. Through the activation of mitogen-activated protein kinase-dependent pathways (Smith et al., 2009) , not only EGF stimulates gingival fibroblasts to remove fibrin clot (Chiquet, Katsaros, & Kletsas, 2015) , but also activates matrix metalloproteins, major ECM-proteolytic enzymes involved in the healing of human acute gingival wounds (Smith et al., 2009) . Surprisingly, while fibroblasts are poised to reduce in number during ECM remodelling, these cells were more numerous at PSD16 in sites treated with the concentrations 1 and 10 μg/g, seemingly due to the EGF proliferative effect on these cells as previously reported (Irwin, Schor, & Ferguson, 1994) . Altogether, these histological events were translated clinically by the highest volumes of regenerated tissues within wounds receiving 1 and 10 μg/g up to PSD16, despite the volume diminution ascribed to the swelling subside as observed for the other groups.
The rapid onset and regression of the inflammatory response has a crucial role in coordinating the process of wound healing (Gurtner et al., 2008) . Less inflammatory cells were histologically evidenced in EFG1 and EGF10 at the opposite of SH and EGF50 where persistent inflammatory response up to PSD16 was found. The finding that exogenous EGF attenuates inflammation is in line with an existing evidence accumulated from preclinical (Heck, Laskin, Gardner, & Laskin, 1992; Kim, Lew, Tark, Rah, & Hong, 2010) and clinical trials (Shin et al., 2015) , and may be linked to a substantial decrease of histamine release by monocytes (Babül, Gönül, Dincer, Erdoğan, & Özoğul, 2004) .
Inflammatory cells secrete essential cytokine and growth factors necessary for angiogenesis and stromal cell migration (Eming, Krieg, & Davidson, 2007) . With regard to a recent report demonstrating a substantial increase in vascular endothelial growth factor (VEGF) synthesis by human gingival fibroblasts exposed to EGF in vitro (Pansani et al., 2017) , the elevated neovascularization EFG1 and EGF10 is not a surprising finding and strongly suggests the ability of rhEGF to promote oral mucosa wound healing by facilitating angiogenesis in addition to an earlier resolution of inflammation (Gainza et al., 2015) .
However, an unexpected outcome was the failure of wounds in EGF50 to reepithelialize, which combined with their persistent inflammatory response suggests the development of chronic lesions (Koivisto, Häkkinen, & Larjava, 2011) . Soft tissue swelling and excessive inflammatory response were reported in wounds treated with highly dosed regimen of growth factors (Zara et al., 2011) .
In animal settings of skin wounds, topical treatment with 10 μg/ ml EGF delayed the closure of acute lesions (Breuing et al., 1997) , while less proliferative activity of keratinocytes was depicted for doses of rhEGF superior to 10 μg/g (Hong et al., 2006) . It is believed that a downregulation of epidermal growth factor receptors occurs when cells are maximally stimulated with exogenous EGF, ultimately leading to the deceleration of the wound healing process (Mathers, Sherman, Fryczkowski, & Jester, 1989) . The decrease of lipocortin activity resulting in prostaglandin upregulation and inflammation exacerbation was also reported to explain the detrimental effect of EGF's high dosages (Tripathi, Raja, & Tripathi, 1990 ). The caveat is that dose-associated events might also include neoplastic transformation (Zeng & Harris, 2014) , the short duration of this study, however, limits any conclusion on the effects of high doses of rhEGF as well as the maturation of healing tissue for a longer span of time. 
| CON CLUS ION
